Advertisement

Topics

FORMA Therapeutics Holdings, LLC Company Profile

03:27 EDT 24th June 2018 | BioPortfolio


News Articles [1248 Associated News Articles listed on BioPortfolio]

Forma, U. Oxford collaborate on DUBs for neurodegenerative diseases

Forma Therapeutics Holdings LLC and several units of the University of Oxford are collaborating to identify, validate, and develop deubiquitinating enzyme (DUB) inhibitors for neurodegenerative diseas...

Forma Therapeutics, University of Oxford partner to advance DUB inhibitors development

Forma Therapeutics and the University of Oxford have entered into a collaboration and license agreement to identify, validate and develop deubiquitinating enzyme (DUB) inhibitors for the treatment of ...

Forma Therapeutics, University of Oxford to advance development of DUB inhibitors to treat neurodegenerative diseases

Forma Therapeutics and the University of Oxford have entered into a collaboration and license agreement to identify, validate and develop deubiquitinating enzyme (DUB) inhibitors for the treatment of ...

FORMA Therapeutics Announces Presentation at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

FT-2102 IDH1m Inhibitor Clinical Data Selected for Oral Presentation FORMA Therapeutics (FORMA), a fully-integrated research and development biotechnology company, announced t...

Ubiquigent & Forma enter into multi-year strategic R&D collaboration

Ubiquigent and Forma Therapeutics have entered into a multi-year strategic research and development (R&D) collaboration agreement for the design and development of novel deubiquitylase (DUB) enzym...

Tim Clackson, Ph.D., Named to FORMA Therapeutics Board of Directors

FORMA Therapeutics (FORMA) today announced the appointment of Tim Clackson, Ph.D., former President, Research and Development, ARIAD Pharmaceuticals, Inc. to the company’s Board...

FORMA, University of Oxford collaborate to develop deubiquitinating enzyme inhibitors to treat neuro degenerative diseases

FORMA Therapeutics and the University of Oxford have entered into a collaboration and license agreement to identify, validate and develop deubiquitinating enzyme (DUB) inhibitors for the treatment of ...

FORMA Therapeutics Achieves Key Objective in Collaboration with Celgene Corporation to Advance a Novel Protein Homeostasis Oncology/Immuno-Oncology Program

FORMA Therapeutics announced today that it has successfully completed a critical objective under its strategic collaboration agreement with Celgene Corporation, triggering an undi...

PubMed Articles [448 Associated PubMed Articles listed on BioPortfolio]

El mieloma múltiple (MM) puede afectar al tórax en forma de lesiones óseas, plasmocitomas, infiltraciones pulmonares y derrame pleural. El derrame pleural por infiltración de células plasmáticas...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

El carcinoma de células escamosas de conjuntiva es una neoplasia de la superficie ocular que puede presentarse con distintos patrones macroscópicos. Presentamos el caso de un hombre de 75 años de e...

Clinical Trials [149 Associated Clinical Trials listed on BioPortfolio]

RF Rejuvenation for Pelvic Floor and Vagina

Evaluation of efficacy and safety of the Votiva RF system with the Forma V handpiece for vaginal treatments.

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1674 Associated Companies listed on BioPortfolio]

FORMA Therapeutics

FORMA Therapeutics unlocks intractable targets to create transformative small molecule therapies. The Company is achieving this by applying its proprietary cell-based screening, s...

FORMA Therapeutics Holdings, LLC

FORMA Therapeutics, Inc.

Auven Therapeutics

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. ...

Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company primarily focused on serving the needs of the pediatric marketplace. Commercially-proven branded product f...

More Information about "FORMA Therapeutics Holdings, LLC" on BioPortfolio

We have published hundreds of FORMA Therapeutics Holdings, LLC news stories on BioPortfolio along with dozens of FORMA Therapeutics Holdings, LLC Clinical Trials and PubMed Articles about FORMA Therapeutics Holdings, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FORMA Therapeutics Holdings, LLC Companies in our database. You can also find out about relevant FORMA Therapeutics Holdings, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record